switcherswitcherswitcherswitcher

User login

Who's online

There are currently 0 users and 3 guests online.

Who's new

  • vsn3480
  • fengzhixuan
  • caseybergman
  • tomas81
  • raju_dharna

RSS Feeds

Technorati

clustering

Senior Scientist in Structural Bioinformatics at Lonza Biologics (Cambridge-UK)

Position Senior Scientist in Structural Bioinformatics (Reference APT-SB2)
Organisation Lonza Biologics plc - Advanced Protein Technologies Group
Location Cambridge-UK
Salary Very competitive package

Role:
A vacancy has arisen Lonza biologics - Advanced Protein Technologies group (Cambridge-UK) for a Senior Scientist in Structural Bioinformatics / Computational Biochemistry to develop and expand its technology platform.
Key Responsibilities:
- Develop and run software tools required for protein aggregation analysis, protein stability, conformational characterisation and protein engineering.
- Design and implement modifications to existing tools to expand their current capabilities and throughput. Co-ordinate research activities with other members of APT as well as external collaborators and contractors to consolidate and enhance current in silico platform technology.

Research Scientist in Structural Bioinformatics at Lonza Biologics (Cambridge-UK)

Position Research Scientist in Structural Bioinformatics (Reference. APT-SB1)
Organisation Lonza Biologics plc - Advanced Protein Technologies Group
Location Cambridge-UK
Salary Very competitive package

Role: A vacancy has arisen at Lonza Biologics - Advanced Protein Technologies group (Cambridge-UK) for a Research Scientist on Structural Bioinformatics / Computational Biochemistry to apply and develop its technology platform.
Key Responsibilities:
- Develop and run software tools required for protein aggregation analysis, protein stability, conformational characterisation and protein engineering.
- Implement modifications to existing tools to expand their current capabilities and throughput.
- Co-ordinate research activities with other members of APT as well as external collaborators and contractors to consolidate and enhance existing in silico platform technology.

Syndicate content